Skip to main content
Loading...
/sites/default/files/video/products_banner.mp4
elfabrio

For the treatment of adult patients with Fabry Disease
First approved in May 2023

Learn more
elelyso

For the treatment of Gaucher Disease
First approved in May 2012

Learn more